Trades and observations from a British contrarian stock investor

This blog is not intended to give financial advice. Before investing, do your own research and consult your financial adviser if appropriate. The accuracy of any information included is not guaranteed and may be subject to conjecture or interpretation by Contrarian Investor. Therefore visitors should validate all facts using alternative sources where possible.

Thursday, March 25, 2010

Genzyme falls through stop loss

A tight stop loss on Genzyme (GENZ) at 5% was triggered at the open as the company suffered broker down grades on yesterday's FDA news. The stock is currently down 6.5% at $51.7. 

No comments:

Post a Comment